Supplementary Material:Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: a multi-institutional cohort study
Published: 17 January 2023| Version 1 | DOI: 10.17632/j7fzzdfbgf.1
Contributor:
Shijia ZhangDescription
Supplementary Materials for the manuscript: Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: a multi-institutional cohort study
Files
Categories
Dermatology